21.12.2020
Available in English, Spanish, Italian and Portuguese
21.12.2020
Available in English, Spanish, Italian and Portuguese
21.12.2020
Available in English, Spanish, Italian and Portuguese
This document facilitate the preparation of a risk communication and community engagement strategy for vaccination against COVID-19. Its goal is to help to strengthen the communication and planning capacities of the ministries or secretariats of he...alth and other agencies in charge of communicating about new COVID-19 vaccines in the Americas.
Available in English, Spanish and Portuguese
more
La OPS, dentro de su empeño constante por apoyar a los países de las Américas, publica el presente documento con ánimo de facilitar la elaboración de una estrategia de comunicación de riesgos y participación comunitaria para la vacunación contra la COVID-19. Su finalidad es contribuir a fort...alecer las capacidades y la planificación de la comunicación de los ministerios o secretarías de salud, así como de otros organismos encargados de comunicar en el área de las nuevas vacunas contra la COVID-19 en las Américas.
Available in English, Spanish and Portuguese
more
A Organização Pan-Americana da Saúde, em seu esforço constante e permanente para apoiar os países das Américas, apresenta este documento para facilitar a formulação de uma estratégia de comunicação de riscos e participação comunitária (CRPC) para a vacinação contra o SARS-CoV-2. O in...tuito é contribuir para o fortalecimento das capacidades de comunicação e planejamento dos ministérios e secretarias de saúde, bem como de outros órgãos responsáveis pela comunicação na área das novas vacinas contra a COVID-19 nas Américas.
Available in English, Spanish and Portuguese
more
mRNA vaccines have to potential to end the COVID19 pandemic. How do they work? Are they safe? And how could they've been developed so quickly?
13 April 2021 Policy Brief
This document provides answers to FAQs healthcare providers and staff may have about COVID-19 vaccines
orientaciones provisionales, primera publicación: 24 de mayo de 2021, actualización: 21 de octubre de 2021, actualización: 15 de marzo de 2022
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...urity, and pandemic preparedness and response. The authors examine the state of solidarity at global, regional and national levels, and present case studies on COVAX and on the EU’s turbulent journey through solidarity.
more
These organisations have joined forces to accelerate access to COVID-19 vaccines, therapeutics and diagnostics by leveraging multilateral finance and trade solutions, particularly for low- and middle-income countries.
The aim is to ...ribute-to-highlight medbox">vaccinate at least 40 percent of people in every country by the end of 2021, and at least 60 percent by mid-2022. The effort will track, coordinate, and advance delivery of COVID-19 vaccines, therapeutics and diagnostics, working with governments and partners at the global and local levels to address finance and trade barriers to ensure that vulnerable populations have access to these life-saving tools. It supports the goals of the ACT-Accelerator and complementary initiatives.
more
This is a guidance document for countries and implementing partners on the technical requirements for developing digital information systems for issuing standards-based interoperable digital certificates for COVID-19 vaccination status, and consider...ations for implementation of such systems, for the purposes of continuity of care, and proof of vaccination.
more
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Вакцина против COVID-19 CoronaVac производства компании Sinovac (Sinovac-CoronaVac) July 2021
21.12.2020
Available in English, Spanish, Italian and Portuguese